Heparin vs Placebo for Cardiac Catheterization

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Cardiac Disease

In brief

Patients undergoing cardiac catheterization will be randomized to 3 groups: no anticoagulant, low dose anticoagulant and high dose anticoagulant.

Key facts

Study ID

NCT04374799

Run by

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

People needed

1623

Starts

2020-10-05

Expected to finish

2026-12-01

Last updated by the study team

2026-02-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• diagnostic cardiac catheterization; Small size sheath; patency of the ulno-palmar circulation

You may not qualify if…

• abnormal ulno-palmar circulation; Prior radial artery thrombosis; Prior surgery close to the access site; Emergent cardiac catheterization; History of HIT or allergy to heparin; Patients requiring anticoagulation

Where it is running

• Hamilton Health Sciences — Hamilton, Ontario, Canada (enrolling)
• London Health Sciences Centre — London, Ontario, Canada (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.